Keywords
Epidemiología
Neoplasias hematológicas
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the incidence and mortality trend of childhood leukemia and lymphoma, as well as to estimate survival through the mortality/incidence ratio in Mato Grosso. Methods: Data from the Mato Grosso population-based cancer registry from 2001 to 2017 were analyzed, as well as mortality data from 2001 to 2021 extracted from the Mortality Information System. The analysis consisted of frequencies, adjusted incidence rates (AIR) per million and joinpoint regression results. Survival estimates were calculated using the ratio of numbers of deaths and incident cases [1-(M:I)] from 2013 to 2017. Results: Leukemias accounted for 67.7 % of cases with an incidence TxA 29.9 and 13.9 for lymphomas and the mortality rate, was 18.0. There was a significant downward trend in the incidence of leukemias in both sexes -4.0% and in females -5.5%, while the incidence of lymphomas and mortality for neoplasms remained stable. Survival estimates were 88% and 74% for leukemia and lymphoma. Conclusion: The incidence and mortality rates and survival estimates were intermediate to the epidemiological contexts of high- and middle-income countries, with a significant reduction in the incidence of leukemias.
References
ALLEMANI C, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet, 2018; 391 (10125): 1023-1075.
ASADZADEH VOSTAKOLAEI F, et al. The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. The European Journal of Public Health, 2011; 21 (5): 573-577.
BERTUCCIO P, et al. Childhood cancer mortality trends in Europe, 1990-2017, with focus on geographic differences. Cancer epidemiology, 2020; (67): 101768.
BHAKTA N, et al. Childhood cancer burden: a review of global estimates. The lancet oncology, 2019; 20 (1): e 42-e53.
BRASIL. Instituto Nacional do Câncer José Alencar Gomes da Silva INCA. Estimativa 2023: Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2022.
BRASIL. Ministério da Saúde. Sistema de Informações em saúde - DATASUS. 2021. Disponível em: https://datasus.saude.gov.br/informacoes-de-saude-tabnet/. Acesso em: 03 ago. 2021.
CAMARGO B, et al. Cancer incidence among children and adolescents in Brazil: First report of 14 population‐based cancer registries. International journal of cancer, 2010; 126 (3): 715-720.
CHATENOUD L, et al. Childhood cancer mortality in America, Asia, and Oceania, 1970 through 2007. Cancer, 2010; 116 (21): 5063-5074.
CLEGG LX, et al. Estimating average annual per cent change in trend analysis. Statistics in medicine, 2009; 28 (29): 3670-3682.
COOK MB, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiology Biomarkers & Prevention, 2009; 18 (4): 1174-1182.
CURADO MP, et al. Leukemia mortality trends among children, adolescents, and young adults in Latin America. Revista Panamericana de Salud Pública, 2011; 29 (2): 96-102.
DOLL R, et al. (Ed.). Cancer Incidence in Five Continents: Volume II–1970. Springer Science & Business Media; 2012.
FELICIANO SVM, et al. Incidence and mortality of myeloid malignancies in children, adolescents and Young adults in Brazil: A population-based study. Cancer Epidemiology, 2019; (62): 101583.
FERMAN S, et al. Childhood cancer mortality trends in Brazil, 1979–2008. Clinics, 2013; 68 (2): 219-224.
FERREIRA JMO, et al. Lymphoma subtype incidence rates in children and adolescents: first report from Brazil. Cancer epidemiology, 2012; 36 (4): e221-e226.
FIDLER MM, et al. Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study. BMJ, 2016; 354.
FORCE LM, et al. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017. The Lancet Oncology, 2019; 20 (9): 1211-1225.
GOUJON S, et al. Spatial and temporal variations of childhood cancers: literature review and contribution of the French national registry. Cancer medicine. 2018; 7(10): 5299-5314.
GUPTA S, et al. Treating childhood cancer in low-and middle-income countries. Cancer. Washington DC: The World Bank Group, 2015; 121-46.
HOWARD SC, et al. The My Child Matters programme: effect of public–private partnerships on paediatric cancer care in low-income and middle-income countries. The Lancet Oncology, 2018; 19 (5): e252-e266.
JOHNSTON WT, et al. Childhood cancer: Estimating regional and global incidence. Cancer epidemiology, 2021; (71): 101662.
KAATSCH P. Epidemiology of childhood cancer. Cancer treatment reviews, 2010; 36 (4): 277-285.
KARIM-KOS HE, et al. Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994 2011. Cancer epidemiology, 2016; 42: 72-81.
KIM HJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in medicine, 2000; 19 (3): 335-351.
MARCOS-GRAGERA R, et al. Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years. Clinical and Translational Oncology, 2018; (20): 1289-1301.
PARKIN DM e BRAY F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. European journal of cancer, 2009; 45 (5): 756-764.
REULEN RC, et al. Long-term cause-specific mortality among survivors of childhood cancer. Jama, 2010; 304 (2): 172-179.
SIEGEL DA, et al. Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019. JNCI: Journal of the National Cancer Institute, 2023; 115 (11): 1337-1354.
SILVA NP, et al. Incidence of childhood cancer in Latin America and the Caribbean: coverage, patterns, and time trends. Revista Panamericana de Salud Pública, 2024; 48: e11.
STELIAROVA‐FOUCHER E, et al. International classification of childhood cancer. Cancer, 2005; 103 (7): 1457-1467.
STELIAROVA-FOUCHER E, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. The Lancet Oncology, 2017; 18 (6): 719-731.
STELIAROVA-FOUCHER E, et al. Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991–2010 (Automated Childhood Cancer Information System): a population-based study. The Lancet Oncology, 2018; 19 (9): 1159-1169.
SUNKARA V e HÉBERT JR. The application of the mortality‐to‐incidence ratio for the evaluation of cancer care disparities globally. Cancer, 2016; 22 (3): 487-488.
TRALLERO J, et al. Incidence and time trends of childhood hematological neoplasms: a 36-year population-based study in the southern European context, 1983–2018. Frontiers in Oncology, 2023; (13): 1197850.
WARD ZJ, et al. Estimating the total incidence of global childhood cancer: a simulation-based analysis. The Lancet Oncology, 2019; 20 (4): 483-493.
WHO global initiative for childhood cancer: an overview. In: World Health Organization; Disponível em: https://www.who.int/docs/default-source/documents/health-topics/cancer/who-childhood-cancer-overview-booklet.pdf?sfvrsn=83cf4552_1&download=true
YEH JM, et al. A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Annals of internal medicine, 2010; 152 (7): 409-417.
YOULDEN DR, et al. The incidence of childhood cancer in Australia, 1983–2015, and projections to 2035. Medical Journal of Australia, 2020; 212 (3): 113-120.